OBJECTIVE: To examine the financial impact of quality improvement using Medicare payment data. BACKGROUND: Demonstrating a business case for quality improvement--that is, that fewer complications translates into lower costs--is essential to justify investment in quality improvement. Prior research is limited to cross-sectional studies showing that patients with complications have higher costs. We designed a study to better evaluate the relationship between payments and complications by using quality improvement itself as a measured outcome. METHODS: We used national Medicare data for patients undergoing general (n = 1,485,667) and vascular (n = 531,951) procedures. We calculated hospitals' rates of serious complications in 2 time periods: 2003-2004 and 2009-2010. We sorted hospitals into quintiles by the change in complication rates across these time periods. Costs were assessed using price-standardized Medicare payments, and regression analyses used to determine the average change in payments over time. RESULTS: There was significant change in serious complication rates across the 2 time periods. The top 20% of hospitals demonstrated a 38% decrease (14.3% vs 11.6%, P < 0.001) in complications; in contrast the bottom 20% demonstrated a 25% increase (11.1% vs 16.5%, P < 0.001). There was a strong relationship between quality improvement and payments. The top hospitals reduced their payments by $1544 per patient (95% confidence interval: $1334-1755), whereas the bottom of hospitals had no significant change (average $67 increase, 95% confidence interval: -$123 to $258). CONCLUSIONS: Hospitals that reduced their complications over time had significant reductions in Medicare payments. This demonstrates that payers are clearly incentivized to invest in quality improvement.
OBJECTIVE: To examine the financial impact of quality improvement using Medicare payment data. BACKGROUND: Demonstrating a business case for quality improvement--that is, that fewer complications translates into lower costs--is essential to justify investment in quality improvement. Prior research is limited to cross-sectional studies showing that patients with complications have higher costs. We designed a study to better evaluate the relationship between payments and complications by using quality improvement itself as a measured outcome. METHODS: We used national Medicare data for patients undergoing general (n = 1,485,667) and vascular (n = 531,951) procedures. We calculated hospitals' rates of serious complications in 2 time periods: 2003-2004 and 2009-2010. We sorted hospitals into quintiles by the change in complication rates across these time periods. Costs were assessed using price-standardized Medicare payments, and regression analyses used to determine the average change in payments over time. RESULTS: There was significant change in serious complication rates across the 2 time periods. The top 20% of hospitals demonstrated a 38% decrease (14.3% vs 11.6%, P < 0.001) in complications; in contrast the bottom 20% demonstrated a 25% increase (11.1% vs 16.5%, P < 0.001). There was a strong relationship between quality improvement and payments. The top hospitals reduced their payments by $1544 per patient (95% confidence interval: $1334-1755), whereas the bottom of hospitals had no significant change (average $67 increase, 95% confidence interval: -$123 to $258). CONCLUSIONS: Hospitals that reduced their complications over time had significant reductions in Medicare payments. This demonstrates that payers are clearly incentivized to invest in quality improvement.
Authors: Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland Journal: Health Aff (Millwood) Date: 2010-01-28 Impact factor: 6.301
Authors: John D Birkmeyer; Cathryn Gust; Onur Baser; Justin B Dimick; Jason M Sutherland; Jonathan S Skinner Journal: Health Serv Res Date: 2010-12 Impact factor: 3.402
Authors: Aaron S Fink; Darrell A Campbell; Robert M Mentzer; William G Henderson; Jennifer Daley; Janet Bannister; Kwan Hur; Shukri F Khuri Journal: Ann Surg Date: 2002-09 Impact factor: 12.969
Authors: J Hunter Mehaffey; Robert B Hawkins; Matthew G Mullen; Max O Meneveau; Bruce Schirmer; Irving L Kron; R Scott Jones; Peter T Hallowell Journal: J Am Coll Surg Date: 2016-12-23 Impact factor: 6.113
Authors: Qinyu Chen; Fabio Bagante; Katiuscha Merath; Jay Idrees; Eliza W Beal; Jordan Cloyd; Mary Dillhoff; Carl Schmidt; Adrian Diaz; Susan White; Timothy M Pawlik Journal: World J Surg Date: 2018-09 Impact factor: 3.352
Authors: Jeffrey D Bernstein; David J Bracken; Shira R Abeles; Ryan K Orosco; Philip A Weissbrod Journal: World J Otorhinolaryngol Head Neck Surg Date: 2022-04-18
Authors: Joceline Vuong-Thu Vu; Jun Li; Donald S Likosky; Edward C Norton; Darrell A Campbell; Scott E Regenbogen Journal: Dis Colon Rectum Date: 2020-01 Impact factor: 4.412